Hospitals, research institutes, patient organizations, and partner companies — the institutions behind events, journeys, clinical trials, and specialist centers.
88 organizations in the current directory
31–45 of 88 entries
How results are ordered
Without a selected area, the most recently updated organizations come first. With an area selected, results are ordered by distance to it. Search terms, services and region narrow the results before ordering.
Nothing in this list can be bought. An Organization subscription changes neither where a listing appears nor how it is presented. The expanded card layout follows a completed verification check — and that check is not for sale.
Search for a specialist center, browse trials by sponsor, or follow events run by these organizations.
Diagnostics laboratory
VLVbio is a Swedish biomarker company founded in 2013 and headquartered in Nacka near Stockholm. It develops and markets keratin-18 biomarker assays (M30 and M65) for measuring cell death in liver diseases such as NASH and alcoholic steatohepatitis, as well as in oncology research.
Medical company
evido.health (evido ApS) is a Danish digital health company headquartered in Odense that, in collaboration with Odense University Hospital, develops data-driven software solutions for early diagnosis of chronic liver disease. Its CE-marked product LiverPRO uses routine blood tests for automated risk stratification and detection of MASH, Met-ALD, and alcohol-related liver disease.
Medical company
Perspectum is a medical technology company founded in 2012 in Oxford, United Kingdom, that develops MRI-based diagnostic software for liver disease. Its flagship product, LiverMultiScan, enables non-invasive quantification of liver fat, inflammation, and fibrosis and has received FDA clearance, among other approvals.
Diagnostics laboratory
Roche Diagnostics is the diagnostics division of the Swiss pharmaceutical and diagnostics group F. Hoffmann-La Roche AG, headquartered in Basel and Rotkreuz, Switzerland. The company is one of the world's largest providers of in-vitro diagnostics, including laboratory tests for liver disease, cardiovascular markers, and metabolic parameters.
Diagnostics laboratory
Nordic Bioscience A/S is a Danish biomarker company headquartered in Herlev near Copenhagen, evolved from Osteometer A/S, founded in 1989. The company develops and markets over 100 biomarkers for pharmaceutical research, including for liver, cardiovascular, and metabolic diseases, and operates a CAP/CLIA-accredited laboratory.
Medical company
Madrigal Pharmaceuticals is a US pharmaceutical company headquartered in Conshohocken, Pennsylvania, founded in 2011. The company developed resmetirom (Rezdiffra), the first FDA-approved medication for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) with liver fibrosis.
Medical company
Novo Nordisk A/S is a Danish pharmaceutical company headquartered in Bagsvaerd near Copenhagen, founded in 1923. The company is a global leader in diabetes and obesity therapy (including GLP-1 medicines such as Ozempic and Wegovy) and is increasingly researching cardiometabolic liver diseases such as MASH.
Education provider
The Universidad de Sevilla was founded in 1505 and is one of the oldest and largest universities in Spain, based in Seville, Andalusia. It includes a medical faculty affiliated with several teaching hospitals and is involved in clinical research, including in the field of cardiometabolic and liver diseases.
Clinic
Leiden UMC (Leids Universitair Medisch Centrum, LUMC) is the university medical center of Leiden University, the oldest university in the Netherlands. The hospital traces back to the Academisch Ziekenhuis Leiden, founded in 1878, and has carried the name LUMC since 1996. It combines patient care with biomedical research and academic teaching.
Clinic
Amsterdam UMC is a Dutch university medical center formed in 2018 through the merger of Academic Medical Center (AMC) and VU University Medical Center (VUmc). It is one of the largest academic hospitals in the Netherlands, combining patient care with medical research and teaching at the University of Amsterdam and Vrije Universiteit Amsterdam.
Clinic
Franciscus Gasthuis & Vlietland is a Dutch hospital with locations in Rotterdam and Schiedam, formed in 2015 through the merger of Sint Franciscus Gasthuis and Vlietland Ziekenhuis. It offers a broad range of medical services, including internal medicine and gastroenterology, for the Rotterdam-Rijnmond region.
Research institution
Julius Clinical is a science-led contract research organization (CRO) founded in 2009 in Zeist, Netherlands, spun out of the Julius Center at UMC Utrecht. In November 2025, the company merged with P95 to form P95 Julius Clinical, offering integrated clinical development and real-world evidence studies across Europe.
Clinic
UMC Utrecht (Universitair Medisch Centrum Utrecht) is a Dutch university medical center in Utrecht, closely affiliated with Utrecht University. It is among the leading academic hospitals in the Netherlands and coordinates, among other things, the EU research consortium GRIPonMASH for early diagnosis of metabolic dysfunction-associated steatohepatitis (MASH).
PNO Innovation is a European innovation and grants consultancy with around 22 offices across several European countries, including the Netherlands. The company supports research consortia in applying for and coordinating EU-funded projects, including under the Innovative Health Initiative, and has continued to grow following an investment from Bencis Capital Partners.
Research institution
GRIPonMASH is a European research consortium of 27 partners from 10 countries, funded by the Innovative Health Initiative (IHI) and coordinated by University Medical Center Utrecht (UMCU). The four-year project aims to improve early diagnosis of metabolic dysfunction-associated steatohepatitis (MASH) and is recruiting around 1,000 study participants in each partner country.
